The Peter Attia Drive cover image

#302 - Confronting a metabolic epidemic: understanding liver health and how to prevent, diagnose, and manage liver disease | Julia Wattacheril, M.D., M.P.H.

The Peter Attia Drive

00:00

Exploring the Impact of GLP-1 Agonists on Liver Health

This chapter explores the impact of GLP-1 agonists, particularly semaglutide and tirzepatide, on weight loss and insulin sensitivity for treating non-alcoholic fatty liver disease (NAFLD). It discusses the importance of individualized treatment plans based on clinical evidence, patient BMI, and comorbidities, while also addressing long-term weight management and the need for potential bariatric surgery.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app